drugset / Trial / NCT00134147
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents
Timeline
- Start
- 2005-04
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Inhaled |